Published in Plant Cell Rep on December 13, 2011
Plant-made oral vaccines against human infectious diseases-Are we there yet? Plant Biotechnol J (2015) 0.96
An Env-derived multi-epitope HIV chimeric protein produced in the moss Physcomitrella patens is immunogenic in mice. Plant Cell Rep (2014) 0.80
Immunogenic properties of a lettuce-derived C4(V3)6 multiepitopic HIV protein. Planta (2013) 0.76
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med (1998) 53.26
Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med (2009) 28.62
Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature (2011) 11.07
A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature (1993) 10.36
Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection. J Infect Dis (2005) 10.20
Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies. J Virol (1999) 9.11
The challenge of finding a cure for HIV infection. Science (2009) 8.41
Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. J Infect Dis (2006) 7.98
The survival benefits of AIDS treatment in the United States. J Infect Dis (2006) 7.08
Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine? Nat Med (2009) 6.14
GP120: target for neutralizing HIV-1 antibodies. Annu Rev Immunol (2006) 5.28
The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus. Nat Rev Microbiol (2008) 4.45
The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science (1994) 4.38
Identifying epitopes of HIV-1 that induce protective antibodies. Nat Rev Immunol (2004) 3.69
A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies. Proc Natl Acad Sci U S A (2008) 2.93
Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directed antibody. Nat Struct Mol Biol (2006) 2.50
Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection. J Virol (2003) 2.40
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine. Nat Med (1999) 2.27
HIV infection of the genital mucosa in women. Curr HIV/AIDS Rep (2009) 2.18
Novel mechanism and factor for regulation by HIV-1 Tat. EMBO J (1995) 2.14
Interaction of antigens and antibodies at mucosal surfaces. Annu Rev Microbiol (1997) 2.02
Nef-mediated downregulation of CD4 enhances human immunodeficiency virus type 1 replication in primary T lymphocytes. J Virol (2002) 1.85
Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates. Infect Immun (1998) 1.67
HIV-1 vaccine development after STEP. Annu Rev Med (2010) 1.64
Immunization against bacterial diseases of the intestine. J Pediatr Gastroenterol Nutr (2000) 1.60
Nef-mediated resistance of human immunodeficiency virus type 1 to antiviral cytotoxic T lymphocytes. J Virol (2002) 1.51
HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4(+) cell infection: an IgA gene and functional analysis. Mucosal Immunol (2009) 1.49
Relation between humoral responses to HIV gag and env proteins at seroconversion and clinical outcome of HIV infection. BMJ (1991) 1.48
A review of vaccine research and development: the human immunodeficiency virus (HIV). Vaccine (2006) 1.48
Exposure of the membrane-proximal external region of HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion. Biochemistry (2007) 1.46
Intranasal interleukin-12 is a powerful adjuvant for protective mucosal immunity. J Infect Dis (1999) 1.39
Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond. Hum Vaccin (2011) 1.38
Macrophage signaling in HIV-1 infection. Retrovirology (2010) 1.35
Emergence of multiclass drug-resistance in HIV-2 in antiretroviral-treated individuals in Senegal: implications for HIV-2 treatment in resouce-limited West Africa. Clin Infect Dis (2009) 1.33
How can HIV-type-1-Env immunogenicity be improved to facilitate antibody-based vaccine development? AIDS Res Hum Retroviruses (2011) 1.30
HIV-1 Tat protein as a potential AIDS vaccine. Nat Med (1996) 1.29
High-level expression of human immunodeficiency virus antigens from the tobacco and tomato plastid genomes. Plant Biotechnol J (2008) 1.27
Chimeric plant virus particles as immunogens for inducing murine and human immune responses against human immunodeficiency virus type 1. J Virol (2001) 1.25
Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1. Proc Natl Acad Sci U S A (1997) 1.23
Intracellular destinies: degradation, targeting, assembly, and endocytosis of HIV Gag. AIDS Rev (2007) 1.18
Premature termination and processing of human immunodeficiency virus type 1-promoted transcripts. J Virol (1992) 1.17
Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART. PLoS One (2010) 1.13
Immunization with cocktail of HIV-derived peptides in montanide ISA-51 is immunogenic, but causes sterile abscesses and unacceptable reactogenicity. PLoS One (2010) 1.09
Pathogenesis of lipodystrophy and lipid abnormalities in patients taking antiretroviral therapy. AIDS Rev (2007) 1.06
Production of biopharmaceuticals and vaccines in plants via the chloroplast genome. Biotechnol J (2006) 1.06
A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs. Proc Natl Acad Sci U S A (2004) 1.04
Expression of HIV-1 antigens in plants as potential subunit vaccines. BMC Biotechnol (2008) 1.02
Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys. Vaccine (2004) 1.01
HIV-1 p24-immunoglobulin fusion molecule: a new strategy for plant-based protein production. Plant Biotechnol J (2006) 1.01
High level protein expression in plants through the use of a novel autonomously replicating geminivirus shuttle vector. Plant Biotechnol J (2009) 1.00
Increased breadth and depth of cytotoxic T lymphocytes responses against HIV-1-B Nef by inclusion of epitope variant sequences. PLoS One (2011) 1.00
Structure-based vaccine design in HIV: blind men and the elephant? Curr Pharm Des (2010) 0.99
Analysis of HIV-1 subtype B third variable region peptide motifs for induction of neutralizing antibodies against HIV-1 primary isolates. Virology (2005) 0.98
Comparative ability of various plasmid-based cytokines and chemokines to adjuvant the activity of HIV plasmid DNA vaccines. Vaccine (2008) 0.98
Minimization of chronic plasma viremia in rhesus macaques immunized with synthetic HIV-1 Tat peptides and infected with a chimeric simian/human immunodeficiency virus (SHIV33). Vaccine (2000) 0.97
Biochemical and immunological characterization of the plant-derived candidate human immunodeficiency virus type 1 mucosal vaccine CTB-MPR. Plant Biotechnol J (2008) 0.95
An improved method for monitoring efficacy of anti-retroviral therapy in HIV-infected individuals: a highly sensitive HIV p24 antigen assay. J Clin Lab Anal (1992) 0.94
The human immunodeficiency virus antigen Nef forms protein bodies in leaves of transgenic tobacco when fused to zeolin. J Exp Bot (2008) 0.94
Plant-derived medicines: a novel class of immunological adjuvants. Int Immunopharmacol (2010) 0.93
Production of HIV-1 p24 protein in transgenic tobacco plants. Mol Biotechnol (2002) 0.92
Expression of functional interleukin-12 from mouse in transgenic tomato plants. Transgenic Res (2005) 0.92
Oral immunization with recombinant listeria monocytogenes controls virus load after vaginal challenge with feline immunodeficiency virus. J Virol (2004) 0.91
Roles of HIV-1 auxiliary proteins in viral pathogenesis and host-pathogen interactions. Cell Res (2005) 0.91
Plant based HIV-1 vaccine candidate: Tat protein produced in spinach. Vaccine (2005) 0.89
Unwelcome guests with master keys: how HIV enters cells and how it can be stopped. Top HIV Med (2004) 0.89
Immunogenicity of a novel, bivalent, plant-based oral vaccine against hepatitis B and human immunodeficiency viruses. Biotechnol Lett (2006) 0.89
Correlates of antiviral immune restoration in acute and chronic HIV type 1 infection: sustained viral suppression and normalization of T cell subsets. AIDS Res Hum Retroviruses (2002) 0.88
Expression, intracellular targeting and purification of HIV Nef variants in tobacco cells. BMC Biotechnol (2007) 0.87
Production of mouse interleukin-12 is greater in tobacco hairy roots grown in a mist reactor than in an airlift reactor. Biotechnol Bioeng (2009) 0.87
Broadening our view of protective antibody responses against HIV. Curr HIV Res (2007) 0.86
Optimization of live oral Salmonella-HIV-1 vaccine vectors for the induction of HIV-specific mucosal and systemic immune responses. J Biotechnol (1996) 0.86
Current progress in the development of a prophylactic vaccine for HIV-1. Drug Des Devel Ther (2010) 0.85
Immunogenicity of chloroplast-derived HIV-1 p24 and a p24-Nef fusion protein following subcutaneous and oral administration in mice. Plant Biotechnol J (2011) 0.85
Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization. J Immunol Methods (1998) 0.85
Role of IL-12 in HIV infection and vaccine. Eur Cytokine Netw (2010) 0.85
Bacillus thuringiensis Cry1Ac protoxin is a potent systemic and mucosal adjuvant. Scand J Immunol (1999) 0.84
High-level expression of the HIV-1 Pr55gag polyprotein in transgenic tobacco chloroplasts. Planta (2009) 0.84
Two decades of plant-based candidate vaccines: a review of the chimeric protein approaches. Plant Cell Rep (2011) 0.83
Expression of a single-chain human interleukin-12 gene in transgenic tobacco plants and functional studies. Biotechnol Bioeng (2004) 0.83
Anchorage to the cytosolic face of the endoplasmic reticulum membrane: a new strategy to stabilize a cytosolic recombinant antigen in plants. Plant Biotechnol J (2008) 0.83
A helical epitope in the C4 domain of HIV glycoprotein 120. J Biol Chem (1995) 0.80
In planta expression of HIV-1 p24 protein using an RNA plant virus-based expression vector. Mol Biotechnol (2000) 0.80
Feeding of mice with Arabidopsis thaliana expressing the HIV-1 subtype C p24 antigen gives rise to systemic immune responses. APMIS (2008) 0.78
Is there a role for plant-made vaccines in the prevention of HIV/AIDS? Immunol Cell Biol (2005) 0.78
Interleukin-12 is necessary for the priming of CD4+ T cells required during the elicitation of HIV-1 gp120-specific cytotoxic T-lymphocyte function. Immunology (2008) 0.78
Fruit-specific expression of the human immunodeficiency virus type 1 tat gene in tomato plants and its immunogenic potential in mice. Clin Vaccine Immunol (2007) 0.77
Dicistronic binary vector system-A versatile tool for gene expression studies in cell cultures and plants. J Biotechnol (2010) 0.77
HIV-1 gp120 V3 cholera toxin B subunit fusion gene expression in transgenic potato. Protein Expr Purif (2004) 0.77
Carrier potential properties of Bacillus thuringiensis Cry1A toxins for a diphtheria toxin epitope. Scand J Immunol (2007) 0.77
Production of recombinant HIV-1/HBV virus-like particles in Nicotiana tabacum and Arabidopsis thaliana plants for a bivalent plant-based vaccine. Vaccine (2007) 0.77
Production of a short recombinant C4V3 HIV-1 immunogen that induces strong anti-HIV responses by systemic and mucosal routes without the need of adjuvants. Viral Immunol (2006) 0.76
Preferential expression and immunogenicity of HIV-1 Tat fusion protein expressed in tomato plant. Transgenic Res (2010) 0.76
A novel candidate HIV vaccine vector based on the replication deficient Capripoxvirus, Lumpy skin disease virus (LSDV). Virol J (2011) 0.76
In vivo activity of plant-based interleukin-12 in the lung of Balb/c mouse. BMC Res Notes (2010) 0.76
Therapeutic vaccination with p24-VLP and zidovudine augments HIV-specific cytotoxic T lymphocyte activity in asymptomatic HIV-infected individuals. AIDS Res Hum Retroviruses (1999) 0.75
p24 antigenaemia as a predictor of good immunological responsiveness to zidovudine therapy in asymptomatic HIV infection. AIDS (1992) 0.75
A defined conformational epitope from the C4 domain of HIV type 1 glycoprotein 120: anti-cyclic C4 antibodies from HIV-positive donors magnify glycoprotein 120 suppression of interleukin 2 produced by T cells. AIDS Res Hum Retroviruses (2001) 0.75
Striking phenotypic and functional differences in lamina propria lymphocytes from the large and small intestine of mice. Life Sci (2005) 0.98
Immunohistochemical characterization of the initial stages of Naegleria fowleri meningoencephalitis in mice. Parasitol Res (2004) 0.90
Ingestion of transgenic carrots expressing the Escherichia coli heat-labile enterotoxin B subunit protects mice against cholera toxin challenge. Plant Cell Rep (2007) 0.85
Oral immunogenicity of tomato-derived sDPT polypeptide containing Corynebacterium diphtheriae, Bordetella pertussis and Clostridium tetani exotoxin epitopes. Plant Cell Rep (2010) 0.83
Intranasal coadministration of the Cry1Ac protoxin with amoebal lysates increases protection against Naegleria fowleri meningoencephalitis. Infect Immun (2004) 0.83
Expression of toll-like receptor TLR-2, TLR-3, TLR-4 and TLR-9 is increased in placentas from patients with preeclampsia. Arch Med Res (2011) 0.83
Two decades of plant-based candidate vaccines: a review of the chimeric protein approaches. Plant Cell Rep (2011) 0.83
Expression of an immunogenic F1-V fusion protein in lettuce as a plant-based vaccine against plague. Planta (2010) 0.81
Pretreatment with Cry1Ac protoxin modulates the immune response, and increases the survival of Plasmodium-infected CBA/Ca mice. J Biomed Biotechnol (2010) 0.81
Phenotypic and functional differences between lymphocytes from NALT and nasal passages of mice. Scand J Immunol (2007) 0.81
Cry1Ac protoxin from Bacillus thuringiensis promotes macrophage activation by upregulating CD80 and CD86 and by inducing IL-6, MCP-1 and TNF-α cytokines. Int Immunopharmacol (2013) 0.80
Suppression of the death gene BIK is a critical factor for resistance to tamoxifen in MCF-7 breast cancer cells. Int J Oncol (2013) 0.80
A chloroplast-derived C4V3 polypeptide from the human immunodeficiency virus (HIV) is orally immunogenic in mice. Plant Mol Biol (2012) 0.80
Structural implication of the induced immune response by Bacillus thuringiensis Cry proteins: role of the N-terminal region. Mol Immunol (2004) 0.80
An Env-derived multi-epitope HIV chimeric protein produced in the moss Physcomitrella patens is immunogenic in mice. Plant Cell Rep (2014) 0.80
Immunogenicity of nuclear-encoded LTB:ST fusion protein from Escherichia coli expressed in tobacco plants. Plant Cell Rep (2011) 0.79
Plant-based vaccines for Alzheimer's disease: an overview. Expert Rev Vaccines (2014) 0.78
Developing plant-based vaccines against neglected tropical diseases: where are we? Vaccine (2012) 0.77
Expression of the nucleocapsid protein of porcine reproductive and respiratory syndrome virus in soybean seed yields an immunogenic antigenic protein. Planta (2011) 0.77
A Plant-Derived Multi-HIV Antigen Induces Broad Immune Responses in Orally Immunized Mice. Mol Biotechnol (2015) 0.77
The potential of plants for the production and delivery of human papillomavirus vaccines. Expert Rev Vaccines (2015) 0.76
Production of a short recombinant C4V3 HIV-1 immunogen that induces strong anti-HIV responses by systemic and mucosal routes without the need of adjuvants. Viral Immunol (2006) 0.76
Transgenic carrot tap roots expressing an immunogenic F1-V fusion protein from Yersinia pestis are immunogenic in mice. J Plant Physiol (2010) 0.76
Immunogenic properties of a lettuce-derived C4(V3)6 multiepitopic HIV protein. Planta (2013) 0.76
Mucosal and systemic adjuvant effects of cholera toxin and Cry1Ac protoxin on the specific antibody response to HIV-1 C4/V3 peptides are different and depend on the antigen co-administered. Viral Immunol (2005) 0.76
Effects of luteectomy in early pregnancy on the maintenance of gestation and plasma progesterone concentrations in the viviparous temperate lizard Barisia imbricata imbricata. Reprod Biol Endocrinol (2010) 0.75
Nitric oxide production and nitric oxide synthase immunoreactivity in Naegleria fowleri. Parasitol Res (2007) 0.75